DARMSTADT, Germany (Reuters) - Merck KGaA, the world's largest maker of chemicals for flat screens, gave a cautious 2010 outlook well below market forecasts and cut its dividend reflecting uncertainty over its drugs pipeline. The family controlled drugs-to-chemicals company said on Tuesday it was targeting 3-13 percent growth in core operating profit this year, below the 25 percent seen in ...

Swiss drugmaker Novartis AG said Monday that its meningitis vaccine Menveo has been approved for use in teenagers and adults by the U.S. Food and Drug Administration. Menveo is a vaccine against four common types of bacterial meningitis, which affects between 1,000 and 3 ...

ZURICH (Reuters) - Novartis has won U.S. approval for its key Menveo meningococcal vaccine and got priority review for its oral treatment for multiple sclerosis (MS), underlining the promise of the Swiss group's pipeline. The U.S. Food and Drug Administration has licensed the vaccine to help protect people aged between 11 and 55 years against potentially deadly meningitis ...